PTEN and neoplasm: Factors like HER2 degradation, overexpression of other RTKs, mutation of PI3KCA (PI3K catalytic subunit p110α), and loss of Phosphatase and Tensin Homolog Deleted on Chromosome 10 (PTEN) tumor-suppressive function have been linked with trastuzumab resistance (186).